Oxolinic acid is a quinolone-based antibacterial agent that functions by inhibiting DNA gyrase, an enzyme essential for bacterial DNA replication. Primarily utilized in the treatment of various infections… Read more










Oxolinic acid is a quinolone-based antibacterial agent that functions by inhibiting DNA gyrase, an enzyme essential for bacterial DNA replication. Primarily utilized in the treatment of various infections caused by susceptible Gram-negative bacteria, including urinary tract infections, this compound requires rigorous analytical oversight during pharmaceutical manufacturing. This category offers high-quality reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. Additionally, it features stable isotope-labelled compounds such as deuterated analogues, which are critical for accurate impurity profiling and precise quantification in complex biological matrices. Laboratories use these materials for method validation, stability testing, and routine quality control to ensure regulatory compliance and therapeutic safety. By providing a comprehensive suite of well-characterized analytical standards, this collection supports the critical testing processes necessary for the development and maintenance of oxolinic acid-based products.